News Archive
Dean's Award for Prince of Wales Clinical School Phd Student
Congratulations to Emma Devenney who was recently awarded the Dean's Award for Rising Star PhD student.
Top ten Australian news stories for UNSW Medicine in 2016
The Media Office has advised the School of the top 10 research stories for UNSW Medicine in 2016, measured by total Australian audience reach on international and online media.
Research in our School are featured prominently in the list:
#2 Medical scientists develop 'game-changing' stem cell repair system (April, 4.5 million) - John Pimanda and Vashe Chandrakanthan
Saving Children with Brain Cancer
A new treatment is giving sick kids and their families hope.
TCRN Clinical PhD Scholarship Top-up Awards 2017
Applications are now being accepted for the TCRN Clinical PhD Scholarship Top-up Awards Round 1, 2017.
The 2016 Prince of Wales Clinical School Postgraduate Research Day Prizes
The Prince of Wales Clinical School held their annual Postgraduate Research Seminar Day on 28 October. 14 students gave oral presentations of their research work, with another 22 students completing a poster. The school was delighted to have Professor Cyndi Shannon Weickert as guest speaker on the day, who also participated as a judge for the oral presentations.
Peter Beshara awarded prize for best student paper at national conference
Recently the Australian Physiotherapy Association (APA) ACT Research Symposium was held, on Saturday 10th September at the University of Canberra. The conference is a full day program showcasing current and emerging physiotherapy research from speakers all around Australia.
The ideas man at the interface of engineering and medicine
An exquisite example of research in action, orthopaedic researcher and surgeon Bill Walsh and his team are inventing the biomedical devices of the future.
Professor Bill Walsh is a dynamo. His energy and passion are so vibrant, I swear I can see lightbulbs popping out of his head every few seconds as we talk.
Animal studies show new cancer nanomedicine reduces pancreatic tumour growth
Australian cancer researchers have developed a highly promising technology to deliver gene-silencing drugs to treat pancreatic cancer – the most chemo-resistant and deadly cancer in Australia.
When tested in mice, the new nanomedicine resulted in a 50 per cent reduction in the growth of tumours and reduced the spread of pancreatic cancer.
Surviving cancer – at what cost?
Understanding how chemotherapy-induced nerve damage impacts on the quality of life of Australia’s cancer survivors is the goal of a new survey launched by UNSW.
National Survey of Cancer Survivors
Researchers at UNSW Australia are seeking volunteers who have received neurotoxic chemotherapy (i.e. chemotherapy that can cause damage to the nerves) as a treatment for cancer to complete an online survey. Through this survey, we hope to better understand the impact of side effects of chemotherapy on the lives of Australian cancer survivors.